chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FILLED WITH BLOOD CLOTS; DAMAGE TO HEART; CONSTANT PAIN; This spontaneous report received from a patient via media via a company representative concerned a patient of unspecified age and sex with unspecified race and ethnicity.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination (dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient experienced filled with blood clots, damage to heart, and constant pain. Reporter stated that" cases like me who have damage to our hearts and are filled with blood clots. I have been in constant pain for weeks now". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from constant pain, and the outcome of damage to heart and filled with blood clots was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211232200.; Sender's Comments: V0: 20211232808-COVID-19 VACCINE AD26.COV2.S- filled with blood clots and damage to heart. This event(s) is considered unassessable. The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
slight cough; rubbing nose; slight colds; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced slight cough, rubbing nose and slight clods. Patient also mentioned he had his Covid test yesterday but the result was not yet out and asking now if it was okay to have his 2nd shot tomorrow even in that condition. The patient underwent lab tests and procedures which included Covid test with unknown results on 13Mar2021. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number could not be obtained.
One of my cousin explain that her thyroid is rushed out now from vaccine; This is a spontaneous report from a contactable consumer reported for a patient (cousin). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. Reporter stated that his/her friend wants to take the Pfizer vaccine (Unspecified Vaccine) and reporters friend has 8 goiter's (History) and she has been researching and reporter told her that Pfizer has less reactions than Moderna and she wants to take the Pfizer but she was very concerned about the 8 goiter's, so she was been working with doctor, she just said that, she was not comfortable taking it unfortunately they live in  and delta virus was rapid, so she was afraid not to take it. Reporter asked, regarding any adverse reaction to thyroid because one of his/her cousin explain that her thyroid was rushed out now from vaccine. Further reporter informed friend regarding same, she said oh my gosh, reporter did not know if he/she should take it and should definitely research it. Reporter stated, he/she really need to, he/she got children, need to go. Outcome of the event was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Zoxtavax vaccine give 11-07-2009 subcutaneous into right arm. Patient used to be obese now has excess skin and tissue on arms and abdomen. Patient complained of pain at injection site and extending to right elbow since 11/04/09. Very slight pink 3cm at injection site. No swelling. No induration. Injection date: 11-04-09, Time: 16:30. Date pain reported: 11-13-09. Pain @ time of injection and noted four hours later -> 1 week later.
no adverse event, treatments or outcomes. Vaccine was expired by 1 day Expiration 11/13/2022
HAVRIX was accidentally drawn up with Sterile Diluent (sterile water) and given. We contacted the CDC and will revaccinate. They suggested we report it to VAERS. L Thigh seems more red than usual at injection site (PREVNAR 13 and VARIVAX were given on that thigh), otherwise baby is doing fine.
Site: Pain at Injection Site-Mild, Systemic: Headache-Medium, Systemic: Nausea-Severe, Systemic: Weakness-Severe, Additional Details: Pt also experienced boday aches and ear pain.  As of afternoon on 8-18-21, she was beginning to feel better but still had symptoms present.
Vaccine #2 was given far lower on my arm than should have been given.  Given about 3 inches above my elbow.  I had serious red swelling in this area as large as my hand.  Pain, burning, itching.  After about 1 week the soreness and swelling, redness began to go away.  Still 2 weeks from today I can still fill the knot where shot was given and area is still slightly bruised looking.     I do hope getting this vaccine so low and not in the usual place I see them giving the shot on tv.  Did I get the results of the vaccine that I needed?
Information has been received from a physician concerning a 15 year old female who experienced headache and hallucination after the first dose of GARDASIL (lot # not provided). The patient reported the headache and hallucinations when she came in for the second vaccination. The patient did not seek medical attention. Subsequently, the patient recovered from headache and hallucination. Additional information is not expected.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 05-DEC-2015 at time- 15:19, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L025738 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medications was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 2.8 and 2.4 (unit unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
HCP called to state that the patient was given PROQUAD after a TE event.; no additional AE; This spontaneous report has been received from a nurse, concerning a patient of unknown age and gender. The patient's medical history, concomitant medications, previous drug reactions, and allergies were not provided.  On an unknown date, the patient was administered an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) subcutaneous injection as prophylaxis (strength, dose, route of administration, anatomical location, lot number, and expiration date were not provided) (product storage error). No additional adverse events were reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2303USA006931: US-009507513-2303USA006967: US-009507513-2303USA007002: US-009507513-2303USA006933: US-009507513-2303USA007031: US-009507513-2303USA006940: US-009507513-2303USA006990: US-009507513-2303USA007041:
lethargic, face and neck area swollen, unresponsive, would not stay awake
Shortly after the shot I began feeling sleepy. I slept most of the afternoon. I woke up about 10 o?clock with a lot of pain in my back and shoulders. I was able to go back to sleep and woke up around around eight the next day. My body felt achy from my neck down. I mediately knew something was wrong. I was still sleeping through the morning. The pain throughout my body increased. I was very tired and again having a hell of a headache. The headache increased over the period of a few hours until it was unbearable. I took Tylenol often on to relieve the pain and about two in the afternoon I took my temperature and it was 101.6. I wasn?t too concerned as I?d heard a temperature was normal. However my headache and bodyaches continued to increase to the point where it was horrible.  I began having chills and pulled several blankets over me about an hour later I took my temperature again and it was 103. I became concerned and called my doctors office. She advised me to take more Tylenol and put cold compresses on my forehead. And if I didn?t get better to go to the emergency. The cold compress on my forehead really helped me feel better. And shortly my temperature began to come down The pain in my head lightened up a little into the evening and I was able to sleep normally. The next day I still felt achy and tired and fatigued. However the extreme pain through my shoulders my neck and my head was mostly gone.
adverse reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ADVERSE REACTION (adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (adverse reaction). At the time of the report, ADVERSE REACTION (adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator. No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: follow up received on 19/05/21 with No new information
Pt. was accidentally given a meningococcal vaccine instead of Kinrix , due to his brother and his non compliant behavior,  the wrong vaccine was picked up and given.
A-fib and consistent elevated resting heart rate of 120-153  for two weeks   seems to be calming down now  but on meds  Eliquest 5mg bid    Metoprolol succinate 25mg  QD Flecainide actate 100mg bid
ACHES, CONSTANT FATIGUE, STIFFNESS\PAIN IN KNEES, RESTLESSNESS\SLEEP DISRUPTION, DEVELOPMENT OF BUMP IN THE LEFT SIDE OF FACE (HAD REDUCED SIGNIFICANTLY BUT NOT COMPLETELY HEALED)
This spontaneous report as received from a registered nurse refers to her. The patient's medical history included NTH barr and fibromyalgia. The patient's current condition included with latex allergy. On an unknown date, the patient was vaccinated with M-M-R II vaccine (strength, dose, route of administration, anatomical location, indication, lot # and expiration date not reported). She had received 4 separate M-M-R II injections over her lifetime. The patient was not pregnant. No concomitant medication was reported. The patient stated that she had never seroconverted for mumps. On an unknown date in October 1966, the patient was exposed to her cousin shortly after he got M-M-R II vaccine. This resulted in her developing rubella on an unknown date in 1966. On an unknown date, the patient was separate M-M-R II naive. The outcome the event she has never seroconverted for mumps was reported as not recovered. The outcome of rubella and MMR naive was reported as recovered. The patient did not receive treatment for the events but sought medical attention. On an unknown date, titers for mumps were completed. A product quality complaint (PQC) was not reported. Additional information has been requested.
no previous history of covid and was fully vaccinated being very sick due to the delta variant; no previous history of covid and was fully vaccinated being very sick due to the delta variant; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for three patients. This is one of three reports. A patient of unspecified age and gender received BNT162B2 (Batch/Lot number was not reported), dose 1 and dose 2, both via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient with no previous history of covid and was fully vaccinated being very sick due to the delta variant, and was in the hospital. The outcome of event was unknown.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101042703 Same reporter/event/drug, different patient;US-PFIZER INC-202101094644 Same reporter/event/drug, different patient
Nerve Damage in both lower legs between the foot and the knee causing pain, numbness, sensitivity to temperature,
Onset of macular papular rash and sore throat on 9/3/02. Started Amoxicillin. 9/4/02 Returned to clinic with worsening rash. 9/5/02 Returned to clinic with abdominal pain, temperature 101 and abdominal pain.
patient came in for the Moderna Bivalant booster and the wrong Moderna Booster was administered
Redness and swelling at shot site, fever, body aches, headache, nausea
He remained BiPAP dependent and unable to manage secretions.  Hemodialysis was continued.  He declined required intubation and then initiation of pressor support.  He was covered for sepsis without significant improvement.  He was not stable enough to consider tracheostomy and that procedure was delayed.  Information was obtained from the outside hospital indicating that he had metastatic adenocarcinoma in the left pleural effusion.  Discussions were then held with his family regarding appropriate levels of care.  As they were considering he developed a brief arrest from which he was resuscitated.  After resuscitation the family did make him DNR active.  They agreed to discontinue hemodialysis with plans to withdraw the ventilator later this week.  However the patient became progressively hypotensive and bradycardic and expired at 7:05 a.m. on 12/14.  I notified his wife.
Fluzone high dose given to 54 year old, no AE; Fluzone high dose given to 54 year old, no AE; Initial information received on 04-Nov-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 54 years old patient who received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot number not reported via unknown route in unknown administration site, on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.
Information has been received from a physician concerning a 4-year-old female who on 26-MAR-2007 was vaccinated with a 0.5 ml booster dose of Varivax. On 26-MAR-2007, following vaccination, the patient experienced a severe allergic reaction, a rash, became very lethargic and had breathing problems. Unspecified medical attention was sought and the patient was given BENADRYL and symptoms resolved. No product quality complaint was involved. The physician considered the patient's reactions to be life threatening. Additional information has been requested.
Leg swelled up the size of a grapefruit. Developed an egg allergy that he did not have before.
He felt like he was having flu-like symptoms and his primary care physician gave him vitamin B. His health began to decline and on his birthday he had begun to have fluid build-up in the legs. Shortly thereafter he complained of urinating himself. He was taken to the hospital when he fell and could not get up. My husband knows more about the symptoms because he carried him into several hospitals which all discharged him until he finally died in the third hospital.
About 2.5 hrs after the vaccine I developed a headache (and still have it the following day, about 17.5 hours later). Painwise it kind of feels like a moderately-bad red wine hangover. Not a migraine, but unpleasant and getting in the way of working today. I took ibuprofen and it did not seem to reduce the pain. About 4 hours after the vaccine I developed very bad chills -- could not get warm with heavy blankets, robe, hat, scarf, heating pad. I am still experiencing them now (about 17.5 hours after the injection), but they are intermittent. Along with the chills came pretty bad pain (5? 6?) at injection site, which was the RT shoulder (I had rotator cuff surgery on this shoulder two months ago). It is now the day following the injection and I've just started presenting with diarrhea.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 4:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 4:00 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 23.32.  Concomitant products were not provided.  On 13-Feb-2021, Excursion time was 09 AM, temperature was 32, total doses given for the day was 152, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 9-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
For the first week after the shot I got some nausea and fatigue. Within a week of getting the third dose of the vaccine I started to get some chest discomfort. I had a metallic taste in my mouth. On my second week my blood pressure was intermittently high. It is normally well controlled. I had a rash on my left hand that started to spread to my wrist and up my arm to my neck area. I also got swelling in my left hand within the next couple of weeks. I then had tingling in my left arm. One month after the vaccine I had some dizziness, and my heart rate was at 140 and it would not come down. I went to the ER and it required Cardioversion to correct my heart beat. They had identified Tachycardia. I did have some problems with my blood pressure after the second dose of the vaccine. 04/3/2021 and 04/05/2021. After five weeks the problems with my arm have subsided. My heart rate has been stable as well as my blood pressure is controlled. Rash and swelling in hand with the chest discomfort: 11/29/2021.
Case number PHEH2014US020252 is an initial spontaneous report received from a pharmacist on 07 OCT 2014. This report refers to a patient of unknown demographics. Past medical history and concomitant medication were not reported. The patient was inadvertently vaccinated with a FLUCELVAX 2014/2015 (batch number: not reported) via the intravenous route instead of intramuscular route on an unknown date by a trainee nurse. No adverse event was reported following this administration error (wrong route of administration). Reporter ws trying to follow up for more information.
Information has been received from a registered nurse concerning a patient who on 27-MAY-2008 was vaccinated subcutaneously with a 0.5 ml dose of ZOSTAVAX vaccine (Oka/Merck) (MSD) due to medical error. The patient was not experiencing any known symptoms. The nurse stated that the error was her fault. It had nothing to do with packaging  or anything else. The nurse was disturbed several times while dispensing the medication and she didn't even realize that she grabbed the wrong one until later that evening when she doing the chart. She has since separated the two products in their freezer. In the hopes of preventing others in the office from doing it again. She also stated that the patient was in the office of 30-MAY-2008 and the patient looked and acted fine The patient's siblings also had an adverse experience with ZOSTAVAX vaccine (Oka/Merck) (WAES0805USA05808 & WAES0806USA07719). Additional information has been requested.
Death--Patient woke up in morning and c/o not feeling well. Died in route to hospital.